Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
about
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingAnti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer CellsThe aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasisSOX4 transcriptionally regulates multiple SEMA3/plexin family members and promotes tumor growth in pancreatic cancerDysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Aryl hydrocarbon receptor ligands in cancer: friend and foe.Hepatitis B virus replication and sex-determining region Y box 4 production are tightly controlled by a novel positive feedback mechanism.Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.Aryl hydrocarbon receptor-mediated induction of the microRNA-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin.Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.Regulation of breast cancer tumorigenesis and metastasis by miRNAs.MicroRNAs in cancer therapeutic response: Friend and foemicroRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.CDC42 expression is altered by dioxin exposure and mediated by multilevel regulations via AhR in human neuroblastoma cells.Diverse roles of miR-335 in development and progression of cancers.AhR expression is increased in hepatocellular carcinoma.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.The Complex Biology of the Aryl Hydrocarbon Receptor and Its Role in the Pituitary Gland.Low levels of the AhR in chronic obstructive pulmonary disease (COPD)-derived lung cells increases COX-2 protein by altering mRNA stability.Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference.Efficacy in Treating Lung Metastasis of Invasive Breast Cancer with Functional Vincristine Plus Dasatinib Liposomes.Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor.
P2860
Q28087571-610B8143-6D91-407D-A963-5C8ABEF2342DQ28260352-3031BD57-0788-400F-92EE-A9251978B377Q28554754-DA492E48-E601-4325-8E0E-AE503918D400Q33648812-75E5AE0E-363D-4344-8125-3C00DC7DA861Q34485137-1642430E-D066-4A30-AC6B-FAD9047E7FA9Q34515596-296CFB3D-8BAE-4345-8149-BBCA82846E79Q35094742-386F902D-E6BF-45E2-96C4-2CF93B6920C6Q35458027-78E4FD77-84B0-47E8-A649-B4BA55844F82Q35599865-D84C6C6E-606B-4E79-9E7A-8B6CAE6238D9Q36069377-07F684CF-95C3-4777-841F-66FEE94ED1FCQ36161820-01940286-52AC-48A1-92D6-F7E99B827F63Q36335539-7815F6A9-1D5E-432D-A8AC-4B953EA50037Q37031952-3B5D8210-7460-4006-A8B7-924F900D4748Q37108803-B0BB693D-3C6E-4DBE-9C73-00BADD76C3C1Q37287429-310F2F76-79C5-464F-9D2B-7B037E8A8D4DQ37549093-2EB88EEB-12E5-48EC-BBB2-17FD0EA276A3Q38068926-4CFE50C1-2A88-44ED-AF69-1DA935D93E17Q38258754-114FFA50-20C5-4A9E-AFC2-471F621F8D53Q38336073-D1A4A439-F291-4895-8C62-0AAF5565A885Q38599053-FECE932C-2066-4A75-86C6-A017D0AAE52FQ38975536-BEABD427-0C18-4BD1-81ED-3276D44813D1Q39172696-6F268A17-85AA-4A9C-A373-90007C43ACD3Q39309007-2AAE84D3-E218-486A-B6CC-34AF0E1C5A97Q39387486-25C862CF-72E5-4F7A-B645-8502A8C555C2Q41154446-BEDCB86B-4791-4F6B-BCBB-2532C526A937Q47109270-B42BFABB-A6DA-4619-A4BA-F8F0715ECC52Q47130059-B3F7205D-C5D9-4197-A19B-83F9705DF75FQ47230585-C40C833F-0A75-4D76-8BE3-36AC0FD8DB93Q48226422-55A67054-333B-492C-AC9F-8E03138BF991Q48297415-9F2516AE-D50C-4213-A2D7-AFD0125AF054Q48637960-CF10D837-07C5-4025-B1F9-4605BE9242F4Q49502234-30749FEC-B7D4-41B2-90B7-9A63D35419CBQ54997230-48005D28-61C7-4DE1-B21C-293ACC1D1660
P2860
Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aryl hydrocarbon receptor agon ...... negative breast cancer cells.
@ast
Aryl hydrocarbon receptor agon ...... negative breast cancer cells.
@en
type
label
Aryl hydrocarbon receptor agon ...... negative breast cancer cells.
@ast
Aryl hydrocarbon receptor agon ...... negative breast cancer cells.
@en
prefLabel
Aryl hydrocarbon receptor agon ...... negative breast cancer cells.
@ast
Aryl hydrocarbon receptor agon ...... negative breast cancer cells.
@en
P2093
P2860
P921
P1476
Aryl hydrocarbon receptor agon ...... r negative breast cancer cells
@en
P2093
Brad Amendt
Huojun Cao
KyoungHyun Kim
Stephen Safe
P2860
P304
P356
10.1158/1535-7163.MCT-11-0548
P577
2011-10-27T00:00:00Z